ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,183,795 | $49,026,000 | 25.32% |
| Miura Global Management | 960,000 | $21,552,000 | 5.62% |
| Selkirk Management LLC | 440,000 | $9,878,000 | 5.40% |
| NEXT CENTURY GROWTH INVESTORS LLC | 505,633 | $11,351,000 | 1.36% |
| Geneos Wealth Management Inc. | 407,429 | $9,146,000 | 0.91% |
| Trellus Management Company, LLC | 29,186 | $655,000 | 0.90% |
| Cannell & Co. | 1,096,239 | $24,611,000 | 0.85% |
| CHARTIST INC /CA/ | 64,765 | $1,453,974,000 | 0.68% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $3,480,000 | 0.58% |
| Intrinsic Edge Capital Management LLC | 102,082 | $2,292,000 | 0.45% |